These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35947101)

  • 1. Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application.
    Gessner L; Thevis M; Rothschild MA; Jübner M
    Drug Test Anal; 2022 Oct; 14(10):1744-1761. PubMed ID: 35947101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing.
    Guddat S; Fußhöller G; Beuck S; Thomas A; Geyer H; Rydevik A; Bondesson U; Hedeland M; Lagojda A; Schänzer W; Thevis M
    Anal Bioanal Chem; 2013 Oct; 405(25):8285-94. PubMed ID: 23877183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
    Sobolevsky T; Rodchenkov G
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of sulfate metabolites of the doping agents oxandrolone and danazol using high performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Viet L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():1-9. PubMed ID: 27394004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled administration of dehydrochloromethyltestosterone in humans: Urinary excretion and long-term detection of metabolites for anti-doping purpose.
    Loke S; de la Torre X; Iannone M; La Piana G; Schlörer N; Botrè F; Bureik M; Parr MK
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105978. PubMed ID: 34418529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.
    Balcells G; Gómez C; Garrostas L; Pozo ÓJ; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):983-993. PubMed ID: 27686240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS detection of unaltered glucuronoconjugated metabolites of metandienone.
    Esquivel A; Pozo OJ; Garrostas L; Balcells G; Gómez C; Kotronoulas A; Joglar J; Ventura R
    Drug Test Anal; 2017 Apr; 9(4):534-544. PubMed ID: 27237125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of clostebol sulfate metabolites in Caucasian population.
    Balcells G; Pozo OJ; Garrostas L; Esquivel A; Matabosch X; Kotronoulas A; Joglar J; Ventura R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():54-63. PubMed ID: 27085012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.
    Schänzer W; Geyer H; Fusshöller G; Halatcheva N; Kohler M; Parr MK; Guddat S; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2006; 20(15):2252-8. PubMed ID: 16804957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient approach for the detection and identification of new androgenic metabolites by applying SRM GC-CI-MS/MS: a methandienone case study.
    Polet M; Van Gansbeke W; Van Eenoo P; Deventer K
    J Mass Spectrom; 2016 Jul; 51(7):524-34. PubMed ID: 27434811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination - insights from metandienone metabolism.
    Parr MK; Zöllner A; Fusshöller G; Opfermann G; Schlörer N; Zorio M; Bureik M; Schänzer W
    Toxicol Lett; 2012 Sep; 213(3):381-91. PubMed ID: 22885098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Metabolism of Methyltestosterone and Metandienone: Detection of Novel A-Ring Reduced Metabolites.
    Loke S; Liu L; Wenzel M; Scheffler H; Iannone M; de la Torre X; Schlörer N; Botrè F; Keiler AM; Bureik M; Parr MK
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33802606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new sulphate metabolite as a long-term marker of metandienone misuse.
    Gómez C; Pozo OJ; Garrostas L; Segura J; Ventura R
    Steroids; 2013 Dec; 78(12-13):1245-53. PubMed ID: 24055830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening anabolic androgenic steroids in human urine: an application of the state-of-the-art gas chromatography-Orbitrap high-resolution mass spectrometry.
    Ji Z; Liao L; Ge Y; Liu M; Fang X; Sun H; Zheng S; Deng X
    Anal Bioanal Chem; 2024 May; 416(13):3223-3237. PubMed ID: 38573345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo metabolism of the anabolic-androgenic steroid oxandrolone in the horse.
    Harding C; Viljanto M; Cutler C; Habershon-Butcher J; Biddle S; Scarth J
    Drug Test Anal; 2022 Jan; 14(1):39-55. PubMed ID: 34378336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP21-catalyzed production of the long-term urinary metandienone metabolite 17beta-hydroxymethyl-17 alpha-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping.
    Zöllner A; Parr MK; Drăgan CA; Dräs S; Schlörer N; Peters FT; Maurer HH; Schänzer W; Bureik M
    Biol Chem; 2010 Jan; 391(1):119-27. PubMed ID: 19919183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HepG2 as promising cell-based model for biosynthesis of long-term metabolites: Exemplified for metandienone.
    Zschiesche A; Chundela Z; Thieme D; Keiler AM
    Drug Test Anal; 2022 Feb; 14(2):298-306. PubMed ID: 34705329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry.
    Schänzer W; Delahaut P; Geyer H; Machnik M; Horning S
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):93-108. PubMed ID: 9001957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.